-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - Of further
interest, while bevacizumab is only labeled for use in patients with
brain, breast, colorectal … and peritoneum (150.x to 159.x); and 13
percent malignancies of bone, connective tissue, skin and breast … intrathoracic organs (160.x
to 165.x) in 17 percent; and malignancy
of bone, connective tissue, skin, and breast
-
effectivehealthcare.ahrq.gov/sites/default/files/epstein.pdf
January 01, 2011 - every time
Complicated:
• Sending
rocket to
the moon
• Mastectomy vs lumpectomy/radiation for breast
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
September 15, 2014 - states that 2 new studies that examined
the relationship between vitamin D and calcium intake
and breast … adults.
37 Peer Reviewer 3 Methods For the most part yes unclear why for the subset
analysis for breast … cancer for the WHI study was not
included
We have added the post hoc analysis for breast
and colorectal … We have added the post hoc analysis for breast
and colorectal cancer and for hip fracture
conducted … We have added the data and a discussion of the
hip fracture, colorectal cancer, and breast
cancer findings
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
October 01, 2016 - is the influence of maternal intakes of n-3
fatty acids or the n-3 fatty acid content of maternal
breast … 3 FA) or n-3 FA-supplemented
infant formula or intakes of n-3 FA from sources
other than maternal breast … n-3 fatty acids from foods if
concentrations are quantified in food frequency
questionnaires
o Breast … The current report identified one RCT that found that
DHA supplementation of breast-feeding mothers … Only one of seven prospective
observational studies found higher concentrations of breast
milk n-3
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
March 18, 2014 - Breast
Cancer Res Treat. 2013 Apr;138(3):795-806.
doi:10.1007/s10549-013-2486-1. … For example, it is important to
recognize pre-frailty in breast cancer survivors. … Risk of
ischemic heart disease in women after
radiotherapy for breast cancer. … A
prospective model of care for breast cancer
rehabilitation: Function. … Frailty in older breast cancer survivors: Age,
prevalence, and associated factors.
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-3rdplace_tympanic.pdf
October 08, 2025 - Bottle-fed vs. breast-fed
2. Passive cigarette smoking exposure
3.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
January 01, 2021 - Breast Reconstruction After Mastectomy DOI: 10.23970/AHRQEPCCER245
4. … Overview of Breast Reconstruction after Mastectomy EPC Review. … Partial Breast Irradiation for Breast Cancer https://go.usa.gov/xuxyS
13.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
September 15, 2008 - Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities 02/2006
3. … Gastroesophageal
Reflux Disease
6 1 1 4 Yes Yes
Effectiveness of
Noninvasive
Diagnostic Tests
for Breast … Strategies for Gastroesophageal Reflux Disease
• Effectiveness of Noninvasive Diagnostic Tests for Breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
April 01, 2010 - to identify
patients diagnosed in 2006 with one of the following tumor types and stage IV disease:
breast … At JHH/SKCCC, the cancer registry identified patients with stage IV lung,
pancreatic, breast, and colorectal … Not all common malignancies were well-represented
in this study (e.g., breast cancer), and further evaluation … African American
Other
155 (65%)
76 (32%)
7 ( 2%)
73 (62%)
36 (30%)
9 (8%)
Cancer Type
Breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-literacy_research-protocol.pdf
January 22, 2010 - Predictors of pessimistic breast cancer risk
perceptions in a primary care population. … Black-white differences in risk perceptions of breast cancer
survival and screening mammography benefit … Latina patient perspectives about informed treatment
decision making for breast cancer. … Retention and use of breast cancer recurrence risk
information from genomic tests: the role of health … Agreement between scales in the measurement of
breast cancer risk perceptions.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
December 01, 2012 - In 2012, it is
expected to be the fourth most commonly diagnosed cancer (after prostate, breast, and … cancer and aid in determination of
prognosis in breast cancer.”6 Using GEP tests could improve the … Given the current role of GEP testing in patients with breast cancer, questions formulated in a
report … for the AHRQ on GEP testing in patients with breast cancer11 were used to inform this
Technical Brief … A breast cancer prognostic signature
predicts clinical outcomes in multiple tumor
types.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
October 12, 2016 - We acknowledge that not all trials
included a breast fed group for
benchmarking and that we did not … Again, we acknowledge that not all trials
included a breast fed group for
benchmarking and that we … Note: Breast-feeding Danish women were evaluated
for the impact of supplementation during the first … In children with a FADS genotype linked to
a low endogenous LC-PUFA synthesis, breast-
feeding supplying … Therefore, it is
recommended that women who are pregnant or
breast-feeding consume at least 8 and up
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
July 01, 2012 - of the use of non-invasive imaging in addition to standard workup after recall
for evaluation of a breast … Impact of Gene Expression Profiling
Tests on Breast Cancer Outcomes. … Comparative Effectiveness of Core-Needle
and Open Surgical Biopsy for the Diagnosis of
Breast Lesions … Noninvasive Diagnostic Tests for Breast
Abnormalities: Update of a 2006 Review.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
June 16, 2008 - Clinical Cancer Research 2004;10(5):1764-72.
15014030
Breast
Bush DA, Slater JD, Garberoglio C, … A technique of partial breast irradiation utilizing
proton beam radiotherapy: comparison with conformal … Accelerated partial-breast irradiation using proton
beams: initial clinical experience. … Neutron versus photon
radiotherapy for local control in inoperable breast cancer. … Accelerated partial breast
irradiation using proton beams: Initial dosimetric experience.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
September 01, 2011 - outcomes tables, such as those included below from the review of
Medications to Reduce Risk of Primary Breast … Placebo
Invasive breast cancer No difference 7 (4,12) †
+++
9 (4, 14)
+++
10 (3, 17)
++
Estrogen … Comparative Effectiveness of Medications
to Reduce Risk of Primary Breast Cancer in
Women.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-utilization-seniors_research.pdf
June 01, 2012 - heart
disease.6 Cancer is indicated if one or more of the following cancers are
classified: female breast … Part B, fee for service coverage, survived six months.
** Dual / Nondual monthly status changes.
† Breast … Part B, fee for service coverage, survived six months.
** Dual / Nondual monthly status changes.
† Breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
May 18, 2015 - from fish and other marine sources, some were from dietary supplements,
some were indirect (through breast … is the influence of maternal intakes of n-3 fatty acids or the n-3 fatty
acid content of maternal breast … -3 FA) or n-3 FA-supplemented infant formula or
intakes of n-3 FA from sources other than maternal breast … fatty acids was
assessed during pregnancy
§ Children whose exposure to n-3 fatty acids (through breast … n-3 fatty acids from foods if concentrations are quantified
in food frequency questionnaires
§ Breast
-
effectivehealthcare.ahrq.gov/sites/default/files/toc.pdf
January 01, 2007 - Effect
Estimates from Risk-Adjustment and Instrumental Variable Methods: Surgery for Early-
Stage Breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
February 01, 2017 - 26, all
histologies
89Sr with dendritic
cell vaccine
40 0 NR NR 58% at 36 mo
Yamada,
201214
16, breast … Concurrent use of Sr-89
chloride with zoledronic acid is safe and effective for breast cancer
patients … Bone-related complications
and quality of life in advanced breast cancer: Results from a
randomized phase … versus zoledronic acid in the treatment of bone
metastases in patients with advanced cancer (excluding breast … Denosumab compared with
zoledronic acid for the treatment of bone metastases in patients with
advanced breast
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
January 01, 2012 - A well-known example
is the use of tamoxifen for the prevention of breast cancer. … They then estimated, for each outcome and based on the Breast Cancer Prevention Trial, the
expected … Weighing the risks and benefits of tamoxifen
treatment for preventing breast cancer. … Tamoxifen for the prevention of breast cancer:
current status of the National Surgical Adjuvant
Breast … The International Breast
Cancer Study Group. Cancer Treat Rev. 1993; 19
Suppl A:73-84.
58.